Literature DB >> 17211679

Copper entry into human cells: progress and unanswered questions.

Edward B Maryon1, Shannon A Molloy, Adriana M Zimnicka, Jack H Kaplan.   

Abstract

In this brief review we summarize what is known about the role of hCTR1 in mediating the entry of copper into human cells. There is a body of information that clearly identifies this protein as being a major source (though not the only source) of copper entry into human cells, and thus a crucial element of copper homeostasis. However, much remains that is poorly understood and key aspects of the physiological roles of hCTR1 and its regulation are only superficially appreciated. The particular characteristics of a transport process that in vivo involves the binding, transmembrane transport and release of a substrate that is not present in a free form in the intracellular or extracellular compartments poses particular challenges that are not encountered in the transport of more familiar physiologically important metal cations. Thus much of what we have learned about the more commonly encountered transported ions provides an inadequate model for studies of copper homeostasis. In this article we review progress made and identify the major questions that need to be resolved before an adequate description is attained of how copper entry into human cells is mediated and regulated by hCTR1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17211679     DOI: 10.1007/s10534-006-9066-3

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  20 in total

Review 1.  Human copper transporters: mechanism, role in human diseases and therapeutic potential.

Authors:  Arnab Gupta; Svetlana Lutsenko
Journal:  Future Med Chem       Date:  2009-09       Impact factor: 3.808

Review 2.  Structural biology of copper trafficking.

Authors:  Amie K Boal; Amy C Rosenzweig
Journal:  Chem Rev       Date:  2009-10       Impact factor: 60.622

3.  Rate and regulation of copper transport by human copper transporter 1 (hCTR1).

Authors:  Edward B Maryon; Shannon A Molloy; Kristin Ivy; Huijun Yu; Jack H Kaplan
Journal:  J Biol Chem       Date:  2013-05-08       Impact factor: 5.157

4.  Model peptides provide new insights into the role of histidine residues as potential ligands in human cellular copper acquisition via Ctr1.

Authors:  Kathryn L Haas; Allison B Putterman; Daniel R White; Dennis J Thiele; Katherine J Franz
Journal:  J Am Chem Soc       Date:  2011-03-04       Impact factor: 15.419

5.  Fluorescence lifetime imaging of physiological free Cu(II) levels in live cells with a Cu(II)-selective carbonic anhydrase-based biosensor.

Authors:  Bryan J McCranor; Henryk Szmacinski; Hui Hui Zeng; Andrea K Stoddard; Tamiika Hurst; Carol A Fierke; J R Lakowicz; Richard B Thompson
Journal:  Metallomics       Date:  2014-05       Impact factor: 4.526

6.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

7.  The teleos of metallo-reduction and metallo-oxidation in eukaryotic iron and copper trafficking.

Authors:  Daniel J Kosman
Journal:  Metallomics       Date:  2018-02-27       Impact factor: 4.526

8.  Copper transporters and chaperones CTR1, CTR2, ATOX1, and CCS as determinants of cisplatin sensitivity.

Authors:  Kristin M Bompiani; Cheng-Yu Tsai; Felix P Achatz; Janika K Liebig; Stephen B Howell
Journal:  Metallomics       Date:  2016-05-09       Impact factor: 4.526

9.  Copper-triggered aggregation of ubiquitin.

Authors:  Fabio Arnesano; Simone Scintilla; Vincenza Calò; Elena Bonfrate; Chiara Ingrosso; Maurizio Losacco; Teresa Pellegrino; Enrico Rizzarelli; Giovanni Natile
Journal:  PLoS One       Date:  2009-09-16       Impact factor: 3.240

10.  Mechanistic comparison of human high-affinity copper transporter 1-mediated transport between copper ion and cisplatin.

Authors:  Zheng D Liang; David Stockton; Niramol Savaraj; Macus Tien Kuo
Journal:  Mol Pharmacol       Date:  2009-07-01       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.